JPMorgan said the reasons for the recent correction in defence stocks were “unduly exaggerated”. It said the structural story of defence capex growth and indigenisation remains intact as healthy earnings delivery continue.
JPMorgan said the reasons for the recent correction in defence stocks were “unduly exaggerated”. It said the structural story of defence capex growth and indigenisation remains intact as healthy earnings delivery continue.